Management of Wedge Infarct
Identify the Underlying Cause First
The management of a wedge infarct depends entirely on identifying and treating the underlying etiology—most commonly pulmonary embolism in the lungs or thromboembolic disease in the kidneys—rather than treating the infarct itself. 1, 2, 3
A wedge-shaped infarct represents tissue necrosis from arterial occlusion and appears as a pleural-based, wedge-shaped density on imaging. 4 The critical first step is determining whether this results from:
- Pulmonary embolism (most common cause of pulmonary wedge infarcts, occurring in ~30% of acute PE cases) 3
- Septic emboli (from endocarditis—can mimic PE clinically and radiologically) 1
- Vasculitis (ANCA-associated vasculitis can cause renal and splenic wedge infarcts) 2
- Other thromboembolic sources (cardiac thrombus, atrial fibrillation)
Pulmonary Wedge Infarct Management
Immediate Assessment and Treatment
- Initiate anticoagulation immediately if pulmonary embolism is suspected, unless contraindications exist 3
- Obtain CT pulmonary angiography to confirm PE and assess clot burden—the vascular sign (feeding vessel to the wedge-shaped density) is highly specific for infarction 4
- Provide supplemental oxygen to maintain SaO₂ >90% 5
- Administer adequate analgesia with opioids (morphine sulfate) for pleuritic chest pain 5
Anticoagulation Strategy
- Start therapeutic anticoagulation with low-molecular-weight heparin or direct oral anticoagulants as first-line therapy 3
- Continue anticoagulation for minimum 3 months, with duration extended based on risk factors for recurrence 3
Rule Out Alternative Diagnoses
- Obtain blood cultures if patient is febrile or tachycardic to exclude septic emboli from endocarditis 1
- Perform echocardiography to evaluate for vegetations, cardiac thrombus, or structural abnormalities 1
- Consider vasculitis workup (ANCA antibodies, complement levels) if systemic symptoms present 2
Monitor for Complications
- Watch for secondary pneumonia in the infarcted area, which is a common complication 3
- Monitor for post-PE syndrome development over subsequent months 3
- Recognize that radiological resolution takes months—the infarcted area is replaced by fibrotic scar tissue slowly, so persistent imaging abnormalities do not indicate treatment failure 3
Renal Wedge Infarct Management
Initial Evaluation
- Obtain contrast-enhanced CT or ultrasound to confirm wedge-shaped infarcts and assess bilateral involvement 2
- Exclude large vessel, cardiac, and thrombophilic causes through appropriate imaging and laboratory testing 2
- Check ANCA antibodies (particularly PR3 and MPO) if vasculitis suspected based on systemic symptoms 2
Treatment Based on Etiology
For thromboembolic causes:
- Initiate therapeutic anticoagulation similar to pulmonary infarct management
- Evaluate for embolic source (atrial fibrillation, cardiac thrombus, atherosclerotic disease)
For ANCA-associated vasculitis:
- Administer high-dose corticosteroids immediately 2
- Initiate rituximab (CD20 monoclonal antibody) for remission induction 2
- Perform renal biopsy to confirm focal necrotizing glomerulonephritis if diagnosis uncertain 2
Symptomatic Management
- Provide adequate analgesia for flank or back pain, which may be severe 2
- Monitor renal function closely as degree of recovery depends on extent of infarction 2
- Assess infection risk as infarcted tissue is susceptible to secondary infection 2
Common Pitfalls to Avoid
- Do not assume all wedge infarcts are from PE—septic emboli from endocarditis can present identically on plain radiographs and require completely different management 1
- Do not delay anticoagulation waiting for definitive imaging if PE is clinically suspected 3
- Do not expect rapid radiological resolution—infarcted lung tissue takes months to form fibrotic scar 3
- Do not miss vasculitis in patients with flank pain and systemic symptoms—renal infarction is likely underdiagnosed in ANCA-associated vasculitis 2
- Do not overlook the need for echocardiography in febrile patients with pulmonary wedge infarcts to exclude endocarditis 1